{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:18Z","timestamp":1792189158937,"version":"4.4.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.00224","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T15:15:30Z","timestamp":1589555730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis"],"prefix":"10.3389","volume":"10","author":[{"given":"Albert","family":"Dunbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schauwvlieghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheruna","family":"Algoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap J.","family":"van Hellemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Reynders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"Vandecasteele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerina","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Rijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/j.1469-0691.2010.03400.x","article-title":"Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients","volume":"17","author":"Alanio","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1060028016650107","article-title":"Pneumocystis jirovecii pneumonia in the Non-HIV-infected population","volume":"50","author":"Avino","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1128\/JCM.01756-09","article-title":"Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy","volume":"47","author":"Desmet","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/e537722009-001","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"7452604","DOI":"10.1155\/2017\/7452604","article-title":"Risk factors for the mortality of Pneumocystis jirovecii pneumonia in Non-HIV patients who required mechanical ventilation: a retrospective case series study","volume":"2017","author":"Kotani","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12119","article-title":"Practice ASTIDCo. Pneumocystis pneumonia in solid organ transplantation","volume":"4","author":"Martin","year":"2013","journal-title":"Am. J. Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.diagmicrobio.2016.10.005","article-title":"Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations","volume":"87","author":"Montesinos","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/CMR.00013-12","article-title":"Colonization by Pneumocystis jirovecii and its role in disease","volume":"25","author":"Morris","year":"2012","journal-title":"Clin. Microbiol. Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13075-019-1996-6","article-title":"Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole","volume":"21","author":"Park","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","article-title":"Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids","volume":"77","author":"Park","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3201\/eid2009.131668","article-title":"Pneumocystis jirovecii pneumonia in patients with or without AIDS, France","volume":"20","author":"Roux","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1128\/JCM.38.4.1461-1467.2000","article-title":"Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups","volume":"38","author":"Sing","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1007\/s00436-015-4678-6","article-title":"Pneumocystis jirovecii\u2013from a commensal to pathogen: clinical and diagnostic review","volume":"114","author":"Sokulska","year":"2015","journal-title":"Parasitol. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jcv.2015.08.022","article-title":"Clinical evaluation of a multi-parameter customized respiratory TaqMan((R)) array card compared to conventional methods in immunocompromised patients","volume":"72","author":"Steensels","year":"2015","journal-title":"J. Clin. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"CD005590","DOI":"10.1002\/14651858.CD005590.pub3","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","volume":"2014","author":"Stern","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B18","author":"van der Valk","year":"2019","journal-title":"Crasborn"},{"key":"B19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/14787210.2017.1305887","article-title":"Diagnosis and management of Pneumocystis jirovecii infection","volume":"15","author":"White","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00224\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T15:15:33Z","timestamp":1589555733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00224\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":19,"alternative-id":["10.3389\/fcimb.2020.00224"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.00224","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]},"article-number":"224"}}